What You Should Know:
– CentralReach, a leading provider of Autism and Intellectual and Developmental Disabilities (IDD) software, announced the acquisition of SILAS, a company specializing in social and emotional learning (SEL) and behavior solutions…
Continue Reading
The Motor Disorder Society’s Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) is designed to assess bradykinesia, the cardinal symptoms of Parkinson’s disease (PD). However, it cannot capture the all-day variability of bradykinesia outside the clinical…
Continue Reading
Unlearn, an AI-enabled company creating digital twins of clinical trial participants, announced it scored $50 million in Series C funding, bringing its total raise to more than $130 million. Altimeter Capital led the round with…
Continue Reading
Skin diseases pose significant challenges in China. Internet health forums offer a platform for millions of users to discuss skin diseases and share images for early intervention, leaving large amount of valuable dermatology images….
Continue Reading
By Shania Kennedy
February 07, 2024 – University of Virginia (UVA) researchers have developed a machine learning tool to identify factors associated with cardiac fibrosis and predict which drug candidates can help prevent the condition.
Cardiac fibrosis…
Large language models, a form of artificial intelligence, are generating a lot of hype in healthcare circles, primarily because of their potential to transform and improve various aspects of healthcare delivery and management. The…
Continue Reading
Background: As mobile health (mHealth) studies become increasingly productive owing to the advancements in wearable and mobile sensor technology, our ability to monitor and model human behavior will be constrained by participant receptivity. Many…
Continue Reading
In clinical trials, pharmaceutical companies are seeking to optimize operations and improve efficiency by automating and enhancing processes through Artificial Intelligence (AI) and Machine Learning (ML). One area where this can reap tangible benefits…
Continue Reading
Working with the U.S. Department of Veterans Affairs, Mynd Immersive – a technology company that specializes in extended reality therapies for aging adults – will collaborate with VA Immersive, part of the VA’s Office…
Continue Reading
Hematoma expansion (HE) is a modifiable risk factor and a potential treatment target in patients with intracerebral hemorrhage (ICH). We aimed to train and validate deep-learning models for high-confidence prediction of supratentorial ICH expansion,…
Continue Reading
